Skip to main content
RLMD logo

RLMD · Relmada Therapeutics, Inc. · Share Buybacks

Track RLMD — free
$2.90 +0.04 (+1.40%) Play latest call Q3 2026 earnings call transcript
Market Cap
$304.61M
Shares
106.69M
Volume · Nov 19 224.8K Avg daily vol (3M) 1.41M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Remaining Authorization
4,000,000 shares
as of 2014-03-10 · not restated in filings since 2014-09-09

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Quarter Ended Cash Spent
2026-09-30 $0 Δ
2026-06-30 $6,457,890 Δ
2026-03-31 $3,360,000
Key facts CIK 1553643 CUSIP 75955J402 13F (30d) 150 filings 132 filers Visit website Investor relations